The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although incidence of dementia is known to vary between nations, variation within country has not been explored because most incidence studies are single site or have insufficient numbers to compare sites. Few countries have conducted multisite incidence studies in order to facilitate national comparisons. This study aims to provide robust measures of the variation of the incidence of dementia across sites within England and Wales and produce overall estimates by age and sex. METHODS AND FINDINGS: The Medical Research Council Cognitive Function and Ageing Study used identical methodology in five diverse sites across the United Kingdom, each with different risk patterns and mortality rates. Incidence has been estimated using likelihood-based methods between the first two waves of interviews. Incidence rates rise with age, particularly above the age of 75 y, from 6.7 [corrected] (95% confidence interval, 3.8 [corrected]-12.4 [corrected]) per 1,000 person years at age 65-69 y to 68.5 [corrected] (95% confidence interval, 52.5 [corrected]-88.1 [corrected]) per 1,000 person years at age 85 y and above. The rate of increase for both sexes is marked, and continues into the oldest age groups. Hence, it is estimated that approximately 163,000 [corrected] new cases of dementia occur in England and Wales each year. There is no convincing evidence of variation across sites, and incidence rates do not reflect the variations in the prevalence of possible risk factors in these sites. CONCLUSION: There is no evidence, within England and Wales, of variation in dementia incidence across sites. Dementia incidence rates do not tail off at the oldest ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Forette, F., Seux, M.-L., Staessen, J. A., Thijs, L., Birkenhäger, W. H., Babarskiene, M.-R., Babeanu, S., Bossini, A., Gil-Extremera, B., Girerd, X., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03086-4 · Cited by 1,441 · cited 1×
“[13]) is based on the premise that dementia incidence could be reduced if vascular risk”
Background(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
The incidence of dementia: A meta-analysis
Jorm, A. F., & Jolley, D. (1998) · Neurology · doi:10.1212/wnl.51.3.728 · Cited by 903
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758
Self-citationIncidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study
Bachman, D. L., Wolf, P. A., Linn, R. T., Knoefel, J. E., Cobb, J. L., Belanger, A. J., White, L. R., & D'Agostino, R. B. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.515 · Cited by 470
Incidence and Risk of Dementia: The Rotterdam study
Ott, A., Breteler, M. M. B., Harskamp, F. V., Stijnen, T., & Hofman, A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009489 · Cited by 455 · cited 5×
“Implications of Findings Many studies with similar two-phase, two wave designs assume that those individuals who screen negative at baseline could not have dementia (e.g., Rotterdam [1] and Paquid, France [48,49]).”
BackgroundInfluentialEvans, D. A., Bennett, D. A., Wilson, R. S., Bienias, J. L., Morris, M. C., Scherr, P. A., Hebert, L. E., Aggarwal, N., Beckett, L. A., Joglekar, R., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.185 · Cited by 370 · cited 2×
“Although such estimates, on the whole, seem reasonably consistent across the more developed regions of the world, there have been widely divergent estimates reported within the United States (East Boston study [3] versus Chicago, Illinois [8], in which the disorder definition is different, but even between Framingham…”
ResultIncidence of Dementia in a Population Older Than 75 Years in the United Kingdom
Paykel, E. S. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040069009 · Cited by 196 · cited 1×
“, the Cambridge City over 75 cohort [15,16], Melton Mowbray [17], and Gospel Oak [18,19]).”
Background
Cited by
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
“The study using identical methods in UK found no evidence of variation in dementia incidence among five areas in England and Wales.(22) Studies have confirmed that AD incidence in developing countries is generally lower than in North America and Europe.”
MethodResultMatthews, F. E., Arthur, A., Barnes, L. E., Bond, J., Jagger, C., Robinson, L., & Brayne, C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61570-6 · Cited by 1,155
Self-citationThe distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 965
Self-citationEvolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934
Self-citationAge, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Self-citationThe CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Williams-Gray, C. H., Mason, S. L., Evans, J. R., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. A. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305277 · Cited by 681
Self-citationEpidemiology and risk factors of dementia
van der Flier, W. M. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.082867 · Cited by 547
Xie, J., Brayne, C., & Matthews, F. E. (2008) · BMJ · doi:10.1136/bmj.39433.616678.25 · Cited by 438
Self-citationA two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II
Matthews, F. E., Stephan, B. C. M., Robinson, L., Jagger, C., Barnes, L. E., Arthur, A., Brayne, C., Cognitive Function and Ageing Studies (CFAS) Collaboration, Comas-Herrera, A., Wittenberg, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11398 · Cited by 426
Self-citationA major role for cardiovascular burden in age-related cognitive decline
Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 398
Lewczuk, P., Riederer, P., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramirez, A., Parnetti, L., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 307
Jaakkimainen, R. L., Bronskill, S. E., Tierney, M. C., Herrmann, N., Green, D., Young, J., Ivers, N., Butt, D., Widdifield, J., & Tu, K. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160105 · Cited by 305
Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine
Zemek, F., Drtinova, L., Nepovimova, E., Sepsova, V., Korabecny, J., Klimes, J., & Kuca, K. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.914168 · Cited by 299
Matthews, F. E., Brayne, C., Lowe, J., McKeith, I., Wharton, S. B., & Ince, P. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000180 · Cited by 279
“Considerable attrition over time determines that those who remain in the study tend to have been younger and fitter at enrolment [24].”
BackgroundSelf-citationEpidemiological Studies of the Effect of Stroke on Incident Dementia: A Systematic Review
Savva, G. M., Stephan, B. C. M., & the Alzheimer’s Society Vascular Dementia Systematic Review Group (2010) · Stroke · doi:10.1161/strokeaha.109.559880 · Cited by 257
Survival of people with clinical diagnosis of dementia in primary care: cohort study
Rait, G., Walters, K., Bottomley, C., Petersen, I., Iliffe, S., & Nazareth, I. (2010) · BMJ · doi:10.1136/bmj.c3584 · Cited by 221
Low vitamin B-12 status and risk of cognitive decline in older adults
Clarke, R., Birks, J., Nexo, E., Ueland, P. M., Schneede, J., Scott, J., Molloy, A., & Evans, J. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1384 · Cited by 203
“The Oxford Healthy Aging Project study is a component part of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS) that was designed as a UK population-based cohort study of the causes of dementia and cognitive decline (23, 24).”
MethodGeographical variation in dementia: Systematic review with meta-analysis
Russ, T. C., Batty, G. D., Hearnshaw, G. F., Fenton, C., & Starr, J. M. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys103 · Cited by 191
Lafortune, L., Martin, S., Kelly, S., Kuhn, I., Remes, O., Cowan, A., & Brayne, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0144405 · Cited by 165
Self-citationRuss, T. C., Stamatakis, E., Hamer, M., Starr, J. M., Kivimäki, M., & Batty, G. D. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.119479 · Cited by 152
Predictors of ageing-related decline across multiple cognitive functions
Ritchie, S. J., Tucker-Drob, E. M., Cox, S. R., Corley, J., Dykiert, D., Redmond, P., Pattie, A., Taylor, A. M., Sibbett, R., Starr, J. M., et al. (2016) · Intelligence · doi:10.1016/j.intell.2016.08.007 · Cited by 147
“The eighth decade of life is an important time for studying cognitive ageing, because of the doubling in the risk of dementia that occurs across it (Matthews & Brayne, 2005).”
BackgroundRichard, E., Andrieu, S., Solomon, A., Mangialasche, F., Ahtiluoto, S., van Charante, E. P. M., Coley, N., Fratiglioni, L., Neely, A. S., Vellas, B., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.06.012 · Cited by 121
“The required sample size to have sufficient power to detect an effect of the intervention is highly dependent on age [68].”
Alzheimer's disease including focal presentations
Villain, N., & Dubois, B. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1681041 · Cited by 113
Multiple Biological Pathways Link Cognitive Lifestyle to Protection from Dementia
Valenzuela, M. J., Matthews, F. E., Brayne, C., Ince, P., Halliday, G., Kril, J. J., Dalton, M. A., Richardson, K., Forster, G., & Sachdev, P. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.036 · Cited by 100
Self-citationBrown, A., Kirichek, O., Balkwill, A., Reeves, G., Beral, V., Sudlow, C., Gallacher, J., & Green, J. (2016) · Emerging Themes in Epidemiology · doi:10.1186/s12982-016-0053-z · Cited by 78
Tarnanas, I., Tsolaki, M., Nef, T., M. Müri, R., & Mosimann, U. P. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.002 · Cited by 77
Imfeld, P., Brauchli Pernus, Y. B., Jick, S. S., & Meier, C. R. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-121819 · Cited by 72
Mathur, R., Ince, P. G., Minett, T., Garwood, C. J., Shaw, P. J., Matthews, F. E., Brayne, C., Simpson, J. E., Wharton, S. B., & on behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group (2015) · PLOS ONE · doi:10.1371/journal.pone.0118463 · Cited by 52
“The Medical Research Council’s population-based Cognitive Function and Ageing Study (CFAS) has shown that Alzheimer-type pathology is the most common pathology associated with dementia in the ageing population [6], but that there is considerable overlap in the burden of plaques and tangles between individuals with or…”
MethodSelf-citationZhang, L., Xie, J., Yang, J., & Cao, Y. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23263 · Cited by 28
“9& at age 85 years and above (Matthews and Brayne, 2005), which does suggest that something about aging neurons renders them especially susceptible to the ravages of AD (Reese and Taglialatela, 2011).”
BackgroundInfluentialMuzambi, R., Bhaskaran, K., Brayne, C., Smeeth, L., & Warren-Gash, C. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030874 · Cited by 11
Self-citationMerrick, R., & Brayne, C. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240358 · Cited by 18
Self-citation
Metadata
- Authors
- Matthews, F., Brayne, C., & Medical Research Council Cognitive Function and Ageing Study Investigators
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2005-08-23
- Volume
- 2
- Issue
- 8
- Pages
- e193
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2130052234
- Cited by
- 134
- References
- 10
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.